摘要
目的探究急性心肌梗死伴心房颤动患者给予胺碘酮治疗的临床效果。方法选择2014年6月至2016年8月的我院收治的86例急性心肌梗死并发心房颤动患者,随机分为观察组和对照组,各43例。观察组采用胺碘酮,对照组采用美托洛尔,对比两组患者的治疗效果、不良反应情况、生活质量评分及MUIS评分。结果与对照组相比,观察组患者的治疗效果良好,生活质量各项评分明显更高(P<0.05);观察组不良反应发生率仅为4.65%,MUIS评分为(36.82±2.71)分,分别低于对照组的18.60%与(52.16±3.38)分,差异有统计学意义(P<0.05)。结论胺碘酮治疗急性心肌梗死并发心房颤动患者的临床效果非常显著。
Objective To explore the clinical effect of amiodarone in patients with acute myocardial infarction complicated with atrial fibrillation. Methods A total of 86 patients with acute myocardial infarction complicated with atrial fibrillation from June 2014 to August 2016 were selected and randomly divided into observation group and control group,with 43 cases in each group. The observation group received amiodarone, and the control group received metoprolol. The treatment effects, adverse reactions, the scores of life quality and the scores of MUIS were compared between the two groups. Results Compared with the control group, the treatment effect of the observation group was better, and the quality of life scores were significantly higher（P〈0.05）; the adverse reaction rate was only 4.65%, the MUIS score was（36.82 ±2.71） in the observation group, which were respectively lower than 18.60% and（52.16 ±3.38） in the control group, the differences were statistically significant（P〈0.05）. Conclusion The clinical effect of amiodarone in patients with acute myocardial infarction complicated with atrial fibrillation is very significant.
出处
《临床医学研究与实践》
2017年第34期26-27,共2页
Clinical Research and Practice
关键词
急性心肌梗死
胺碘酮
心房颤动
acute myocardial infarction
amiodarone
atrial fibrillation
